-
1
-
-
0003736032
-
-
Global Initiative for Chronic Obstructive Lung Disease, Date last updated: June 11, 2014. Date last accessed: October 14, 2014
-
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2014 Available from: www.goldcopd.org/uploads/users/files/GOLD-Report-2014-Jun11.pdf Date last updated: June 11, 2014. Date last accessed: October 14, 2014.
-
(2014)
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
-
-
-
2
-
-
69249124565
-
Inhaled corticosteroids in COPD: The case against
-
Suissa S, Barnes PJ. Inhaled corticosteroids in COPD: the case against. Eur Respir J 2009; 34: 13-16.
-
(2009)
Eur Respir J
, vol.34
, pp. 13-16
-
-
Suissa, S.1
Barnes, P.J.2
-
3
-
-
84899491531
-
Understanding the GOLD 2011 Strategy as applied to a real-world COPD population
-
Vestbo J, Vogelmeier C, Small M, et al. Understanding the GOLD 2011 Strategy as applied to a real-world COPD population. Respir Med 2014; 108: 729-736.
-
Respir Med
, vol.2014
, Issue.108
, pp. 729-736
-
-
Vestbo, J.1
Vogelmeier, C.2
Small, M.3
-
4
-
-
78049430514
-
Inhaled corticosteroids and the risks of diabetes onset and progression
-
Suissa S, Kezouh A, Ernst P. Inhaled corticosteroids and the risks of diabetes onset and progression. Am J Med 2010; 123: 1001-1006.
-
(2010)
Am J Med
, vol.123
, pp. 1001-1006
-
-
Suissa, S.1
Kezouh, A.2
Ernst, P.3
-
5
-
-
84875990675
-
Inhaled corticosteroid is associated with an increased risk of TB in patients with COPD
-
Kim JH, Park JS, Kim KH, et al. Inhaled corticosteroid is associated with an increased risk of TB in patients with COPD. Chest 2013; 143: 1018-1024.
-
(2013)
Chest
, vol.143
, pp. 1018-1024
-
-
Kim, J.H.1
Park, J.S.2
Kim, K.H.3
-
6
-
-
84870469745
-
Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD
-
Thornton Snider J, Luna Y, Wong KS, et al. Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD. Curr Med Res Opin 2012; 28: 1959-1967.
-
(2012)
Curr Med Res Opin
, vol.28
, pp. 1959-1967
-
-
Thornton Snider, J.1
Luna, Y.2
Wong, K.S.3
-
7
-
-
0030859363
-
Use of inhaled corticosteroids and the risk of cataracts
-
Cumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med 1997; 337: 8-14.
-
(1997)
N Engl J Med
, vol.337
, pp. 8-14
-
-
Cumming, R.G.1
Mitchell, P.2
Leeder, S.R.3
-
8
-
-
50249112115
-
Dose-response relationship for risk of non-vertebral fracture with inhaled corticosteroids
-
Weatherall M, James K, Clay J, et al. Dose-response relationship for risk of non-vertebral fracture with inhaled corticosteroids. Clin Exp Allergy 2008; 38: 1451-1458.
-
(2008)
Clin Exp Allergy
, vol.38
, pp. 1451-1458
-
-
Weatherall, M.1
James, K.2
Clay, J.3
-
9
-
-
84857283681
-
Indacaterol: A review of its use as maintenance therapy in patients with chronic obstructive pulmonary disease
-
McKeage K. Indacaterol: a review of its use as maintenance therapy in patients with chronic obstructive pulmonary disease. Drugs 2012; 72: 543-563.
-
(2012)
Drugs
, vol.72
, pp. 543-563
-
-
McKeage, K.1
-
10
-
-
79953024950
-
Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: A 12-week study
-
Korn S, Kerwin E, Atis S, et al. Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: a 12-week study. Respir Med 2011; 105: 719-726.
-
(2011)
Respir Med
, vol.105
, pp. 719-726
-
-
Korn, S.1
Kerwin, E.2
Atis, S.3
-
11
-
-
79953026850
-
Once-daily indacaterol versus twice-daily salmeterol for COPD: A placebocontrolled comparison
-
Kornmann O, Dahl R, Centanni S, et al. Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebocontrolled comparison. Eur Respir J 2011; 37: 273-279.
-
(2011)
Eur Respir J
, vol.37
, pp. 273-279
-
-
Kornmann, O.1
Dahl, R.2
Centanni, S.3
-
12
-
-
34147214922
-
-
Global Initiative for Chronic Obstructive Lung Disease, Date last updated: April 11, 2011. Date last accessed: October 14, 2104
-
Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of COPD. 2010. Available from: www.goldcopd.org/uploads/users/files/GOLDReport-April112011.pdf Date last updated: April 11, 2011. Date last accessed: October 14, 2104.
-
(2010)
Global Strategy for the Diagnosis, Management and Prevention of COPD
-
-
-
13
-
-
0037322464
-
Minimal important difference of the transition dyspnoea index in a multinational clinical trial
-
Witek TJ Jr, Mahler DA. Minimal important difference of the transition dyspnoea index in a multinational clinical trial. Eur Respir J 2003; 21: 267-272.
-
(2003)
Eur Respir J
, vol.21
, pp. 267-272
-
-
Witek, T.J.1
Mahler, D.A.2
-
14
-
-
20144362569
-
St. George's respiratory questionnaire: MCID
-
Jones PW. St. George's Respiratory Questionnaire: MCID. COPD 2005; 2: 75-79.
-
(2005)
COPD
, vol.2
, pp. 75-79
-
-
Jones, P.W.1
-
16
-
-
84874694081
-
Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD
-
Price D, Yawn B, Brusselle G, et al. Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD. Prim Care Respir J 2013; 22: 92-100.
-
(2013)
Prim Care Respir J
, vol.22
, pp. 92-100
-
-
Price, D.1
Yawn, B.2
Brusselle, G.3
-
17
-
-
0041865230
-
Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: Immortal time bias in observational studies
-
Suissa S. Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies. Am J Respir Crit Care Med 2003; 168: 49-53.
-
(2003)
Am J Respir Crit Care Med
, vol.168
, pp. 49-53
-
-
Suissa, S.1
-
18
-
-
80051593508
-
Withdrawal of inhaled corticosteroids in individuals with COPD - A systematic review and comment on trial methodology
-
Nadeem NJ, Taylor SJ, Eldridge SM. Withdrawal of inhaled corticosteroids in individuals with COPD - a systematic review and comment on trial methodology. Respir Res 2011; 12: 107.
-
(2011)
Respir Res
, vol.12
, pp. 107
-
-
Nadeem, N.J.1
Taylor, S.J.2
Eldridge, S.M.3
-
19
-
-
84903812277
-
Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: A real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)
-
Rossi A, Guerriero M, Corrado A, et al. Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO). Respir Res 2014; 15: 77.
-
(2014)
Respir Res
, vol.15
, pp. 77
-
-
Rossi, A.1
Guerriero, M.2
Corrado, A.3
-
20
-
-
33847172367
-
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
-
Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775-789.
-
(2007)
N Engl J Med
, vol.356
, pp. 775-789
-
-
Calverley, P.M.1
Anderson, J.A.2
Celli, B.3
-
21
-
-
70249107150
-
Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: Analysis from the randomised, placebo-controlled TORCH study
-
Jenkins CR, Jones PW, Calverley PM, et al. Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Respir Res 2009; 10: 59.
-
(2009)
Respir Res
, vol.10
, pp. 59
-
-
Jenkins, C.R.1
Jones, P.W.2
Calverley, P.M.3
|